X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

Full Steam Ahead on Arbitration Says NJ Appellate Court

Seyfarth Synopsis: Earlier this year, in New Prime, the Supreme Court decisively held that the Feder...

Read More >

SCOTUS 2018-2019 Year In Review: “It Means What It Says. . . .”

Perhaps the most shocking aspect of employment-related cases from the 2018-2019 Supreme Court term t...

Read More >

Where the President and Democratic Candidates Stand on Preparing for the Future of Work

Seyfarth Synopsis: In our fourth installment on the presidential candidates’ stances on future of w...

Read More >

Bill Aimed at Removing Authority from NLRB Introduced in the Senate

On October 24, 2019, Senator Mike Lee (R-UT) introduced the Protecting American Jobs Act. The bill,...

Read More >

COVID-19: Distressed M&A in the Era of a Pandemic -- Part 1, Eyes Wide Open

INTRODUCTION - COVID-19 and the ensuing economic turmoil are continuing to adversely impact business...

Read More >

Repurposing Real Estate Development to Counter Weakened Demand: Know the Risks Before Terminating Contracts

Pacta sunt servanda, i.e., agreements must be kept. This applies in both good economies and bad. Co...

Read More >